Dr. Shahaf Peleg is the CEO and co-founder. Dr. Shahaf Peleg received his PhD from the University of Göttingen, Germany in 2010 where he was part of the international Max Planck Research School (IMPRS) of Neuroscience. He later did his postdoctoral training at the University of Munich where he focused on metabolism – epigenetics connectivity during early aging.

Since 2018, his laboratory at the FBN is working mainly on flies and Giant mice. He is seeking to better understand molecular changes that are associated with the progression of aging.He is interested in novel approaches to extend healthy life span, which center around the concept of energy replacement. To this end, he uses recent technology that enables metazoans to harness the energy of light and translate it to chemical energy in their mitochondria. He received the Schilling prize at 2011.